Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.21 | 45.20 |
| PEG Ratio (TTM) | 0.85 | -2.47 |
| P/S Ratio (TTM) | 1.47 | 1.67 |
| P/B Ratio (TTM) | 1.33 | 1.43 |
| P/FCF Ratio (TTM) | 12.41 | 17.24 |
| Price to 5YR AVG Earnings Ratio | 8.16 | 83.66 |
| Price to 5YR AVG FCF Ratio | 18.94 | 35.04 |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.91% | 2.37% |
| ROE (TTM) | 32.55% | 5.21% |
| Net Profit Margin (TTM) | 34.93% | 5.56% |
| ROIC 5YR AVG | 14.06% | 11.18% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10,555.74% | 16.47% | 26.22% |
| Revenue | 3.13% | 5.65% | 1.86% |
| Net Income | 10,584.26% | 14.89% | 24.67% |
| Cash Flow | 101.21% | 30.60% | -20.70% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.48 | 1.56 |
| Quick Ratio (TTM) | 1.09 | 1.03 |
| D/E Ratio (TTM) | 0.88 | 0.23 |
| Interest Coverage (TTM) | 2.57 | 5.64 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 1.82 | 2.29 |
| LTL to 5YR AVG FCF | 9.74 | 2.78 |
| Shares Outstanding Growth 5YR AVG | -1.35% | -8.59% |